Skip to main content
Erschienen in: European Journal of Orthopaedic Surgery & Traumatology 4/2014

01.05.2014 | Original Article

Relationship between post-SARS osteonecrosis and PAI-1 4G/5G gene polymorphisms

verfasst von: Wei Sun, Zirong Li, Zhengcai Shi, Bailiang Wang, Fuqiang Gao, Yurun Yang, Wanshou Guo

Erschienen in: European Journal of Orthopaedic Surgery & Traumatology | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

Objective

To explore the correlation between post-severe acute respiratory symptom (SARS) patients with osteonecrosis, investigate the etiology of post-SARS osteonecrosis and select the sensitive molecular symbols for early diagnosis and distinguish the high-risk population.

Methods

The studied subjects were divided into two groups. Sixty-two post-SARS patients with osteonecrosis were one group, and 52 age- and sex-matched healthy people were as normal controlled group. Empty stomach blood samples from cubital veins were collected from both groups. Plasminogen activator inhibitor (PAI) by means of enzyme-linked immunosorbent assay and PAI-1 4G/5G polymorphism was detected by polymerase chain reaction and solid phase oligonucleotide assay.

Results

The blood agents of post-SARS patients changed obviously with 15.64 ± 13.85 U/ml while the control group 7.96 ± 4.27 U/ml; 4G/4G genotype for the PAI-1 polymorphism detected in post-SARS group was more than that of the control group, but had no statistical significance. The plasma PAI activity was related to homozygote 4G/4G genotype. This reveals that homozygote 4G/4G genotype may be a susceptible gene mark to Chinese osteonecrosis patients.

Conclusion

Plasminogen activator inhibitor-1 is sensitive blood symbol for screening high-risk susceptible population; 4G/4G PAI-1 genotype may be an etiological factor in osteonecrosis.
Literatur
1.
Zurück zum Zitat Jones LC, Hungerford DS (2007) The pathogenesis of osteonecrosis. Instr Course Lect 56:179–196PubMed Jones LC, Hungerford DS (2007) The pathogenesis of osteonecrosis. Instr Course Lect 56:179–196PubMed
2.
Zurück zum Zitat Glueck CJ, Glueck HI, Mieczkowski L et al (1993) Familial high plasminogen activator inhibitor with hypofibrinolysis, a new pathophysiologic cause of osteonecrosis? Thromb Haemost 69:460–465PubMed Glueck CJ, Glueck HI, Mieczkowski L et al (1993) Familial high plasminogen activator inhibitor with hypofibrinolysis, a new pathophysiologic cause of osteonecrosis? Thromb Haemost 69:460–465PubMed
3.
Zurück zum Zitat Glueck CJ, Freiberg R, Glueck HI et al (1995) Idiopathicosteonecrosis, hypofibrinolysis, high plasminogen activator inhibitor, high lipoprotein(a), and therapy with Stanozolol. Am J Hematol 48:213–220PubMedCrossRef Glueck CJ, Freiberg R, Glueck HI et al (1995) Idiopathicosteonecrosis, hypofibrinolysis, high plasminogen activator inhibitor, high lipoprotein(a), and therapy with Stanozolol. Am J Hematol 48:213–220PubMedCrossRef
4.
Zurück zum Zitat Van Veldhuizen PJ, Neff J, Murphey MD et al (1993) Decreased fibrinolytic potential in patients with idiopathic avascular necrosis and transient osteoporosis of the hip. Am J Hematol 44:243–248PubMedCrossRef Van Veldhuizen PJ, Neff J, Murphey MD et al (1993) Decreased fibrinolytic potential in patients with idiopathic avascular necrosis and transient osteoporosis of the hip. Am J Hematol 44:243–248PubMedCrossRef
5.
Zurück zum Zitat Zalavras CG, Vartholomatos G, Dokou E et al (2004) Genetic background of osteonecrosis: associated with thrombophilic mutations? Clin Orthop Relat Res 422:251–255PubMedCrossRef Zalavras CG, Vartholomatos G, Dokou E et al (2004) Genetic background of osteonecrosis: associated with thrombophilic mutations? Clin Orthop Relat Res 422:251–255PubMedCrossRef
6.
Zurück zum Zitat Kerachian MA, Sequin C, Harvey EJ (2009) Glucocorticoids in osteonecrosis of the femoral head: a new understanding of the mechanisms of action. J Steroid Biochem Mol Biol 114:121–128PubMedCrossRef Kerachian MA, Sequin C, Harvey EJ (2009) Glucocorticoids in osteonecrosis of the femoral head: a new understanding of the mechanisms of action. J Steroid Biochem Mol Biol 114:121–128PubMedCrossRef
7.
Zurück zum Zitat Glueck CJ, Freiberg R, Tracy T et al (1997) Thrombophilia and hypofibrinolysis: pathophysiologies of osteonecrosis. Clin Orthop Relat Res 334:43–56PubMed Glueck CJ, Freiberg R, Tracy T et al (1997) Thrombophilia and hypofibrinolysis: pathophysiologies of osteonecrosis. Clin Orthop Relat Res 334:43–56PubMed
8.
Zurück zum Zitat Kim H, Cho C, Cho Y et al (2011) Significant associations of PAI-1 genetic polymorphisms with osteonecrosis of the femoral head. BMC Musculoskelet Disord 14(12):160CrossRef Kim H, Cho C, Cho Y et al (2011) Significant associations of PAI-1 genetic polymorphisms with osteonecrosis of the femoral head. BMC Musculoskelet Disord 14(12):160CrossRef
9.
Zurück zum Zitat Li ZR, Sun W, Qu H, et al (2005) Clinical research of correlation between osteonecrosis and steroid. Zhonghua Wai Ke Za Zhi 15;43(16):1048–1053 Li ZR, Sun W, Qu H, et al (2005) Clinical research of correlation between osteonecrosis and steroid. Zhonghua Wai Ke Za Zhi 15;43(16):1048–1053
10.
Zurück zum Zitat Sun W, Li ZR, Shi ZC et al (2006) Changes in coagulation and fibrinolysis of post-SARS osteonecrosis in a Chinese population. Int Orthop 30(3):143–146PubMedCentralPubMedCrossRef Sun W, Li ZR, Shi ZC et al (2006) Changes in coagulation and fibrinolysis of post-SARS osteonecrosis in a Chinese population. Int Orthop 30(3):143–146PubMedCentralPubMedCrossRef
11.
Zurück zum Zitat Sun W, Wang BL, Liu BL et al (2010) Osteonecrosis in patients after severe acute respiratory syndrome (SARS): possible role of anticardiolipin antibodies. J Clin Rheumatol 16(2):61–63PubMedCrossRef Sun W, Wang BL, Liu BL et al (2010) Osteonecrosis in patients after severe acute respiratory syndrome (SARS): possible role of anticardiolipin antibodies. J Clin Rheumatol 16(2):61–63PubMedCrossRef
12.
Zurück zum Zitat Mont MA, Jones LC, Hungerford DS (2006) Nontraumatic osteonecrosis of the femoral head: ten years later. J Bone Joint Surg Am 88:1117–1132PubMedCrossRef Mont MA, Jones LC, Hungerford DS (2006) Nontraumatic osteonecrosis of the femoral head: ten years later. J Bone Joint Surg Am 88:1117–1132PubMedCrossRef
13.
Zurück zum Zitat Jones LC, Mont MA, Le TB et al (2003) Procoagulants and osteonecrosis. J Rheumat 30(4):783–792 Jones LC, Mont MA, Le TB et al (2003) Procoagulants and osteonecrosis. J Rheumat 30(4):783–792
14.
Zurück zum Zitat Glueck CJ, Freiberg RA, Wang P (2003) Role of thrombosis in osteonecrosis. Curr Hemat Rep (Current Science) 2:417–422 Glueck CJ, Freiberg RA, Wang P (2003) Role of thrombosis in osteonecrosis. Curr Hemat Rep (Current Science) 2:417–422
15.
Zurück zum Zitat Starklint H, Lausten GS, Arnoldi CC (1995) Microvascular obstruction in avascular necrosis. Immunohistochemistry of 14 femoral heads. Acta Orthop Scand 66(1):9–12 Starklint H, Lausten GS, Arnoldi CC (1995) Microvascular obstruction in avascular necrosis. Immunohistochemistry of 14 femoral heads. Acta Orthop Scand 66(1):9–12
16.
Zurück zum Zitat Jones JP Jr (1992) Intravascular coagulation and osteonecrosis. Clin Orthop 277:41–53PubMed Jones JP Jr (1992) Intravascular coagulation and osteonecrosis. Clin Orthop 277:41–53PubMed
17.
Zurück zum Zitat Jones JP Jr (1993) Fat embolism, intravascular coagulation, and osteonecrosis. Clin Orthop 292:294–308PubMed Jones JP Jr (1993) Fat embolism, intravascular coagulation, and osteonecrosis. Clin Orthop 292:294–308PubMed
18.
Zurück zum Zitat Glueck CJ, Freiberg R, Glueck HI (1994) Hypofibrinolysis: a common, major cause of osteonecrosis. Am J Hematol 45(2):156–166PubMedCrossRef Glueck CJ, Freiberg R, Glueck HI (1994) Hypofibrinolysis: a common, major cause of osteonecrosis. Am J Hematol 45(2):156–166PubMedCrossRef
19.
Zurück zum Zitat Gleuck CJ, Freiberg RA, Fontaine RN et al (2001) Hypofibrinolysis, thrombophilia, osteonecrosis. Clin Orthop 386:19–33CrossRef Gleuck CJ, Freiberg RA, Fontaine RN et al (2001) Hypofibrinolysis, thrombophilia, osteonecrosis. Clin Orthop 386:19–33CrossRef
20.
Zurück zum Zitat Glueck CJ, Fontaine RN, Grouppo R (1999) The plasminogen activator inhibitor-1 gene, hypofibrinolysis, and osteonecrosis. Clin Orthop 366(9):133–146PubMedCrossRef Glueck CJ, Fontaine RN, Grouppo R (1999) The plasminogen activator inhibitor-1 gene, hypofibrinolysis, and osteonecrosis. Clin Orthop 366(9):133–146PubMedCrossRef
21.
Zurück zum Zitat Paolo F, Verena S, Suzanne A (2002) Association of plasminogen activator inhibitor-1 genotype with avascular osteonecrosis in steroid-treatment renal allograft recipients. Transplantation 74(8):1147–1152CrossRef Paolo F, Verena S, Suzanne A (2002) Association of plasminogen activator inhibitor-1 genotype with avascular osteonecrosis in steroid-treatment renal allograft recipients. Transplantation 74(8):1147–1152CrossRef
22.
Zurück zum Zitat Asano T, Takahashi KA, Fujioka M (2004) Relationship between postrenal transplant osteonecrosis of the femoral head and gene polymorphisms related to the coagulation and fibrinolytic systems in Japanese subjects. Transplantation 77(2):220–225PubMedCrossRef Asano T, Takahashi KA, Fujioka M (2004) Relationship between postrenal transplant osteonecrosis of the femoral head and gene polymorphisms related to the coagulation and fibrinolytic systems in Japanese subjects. Transplantation 77(2):220–225PubMedCrossRef
Metadaten
Titel
Relationship between post-SARS osteonecrosis and PAI-1 4G/5G gene polymorphisms
verfasst von
Wei Sun
Zirong Li
Zhengcai Shi
Bailiang Wang
Fuqiang Gao
Yurun Yang
Wanshou Guo
Publikationsdatum
01.05.2014
Verlag
Springer Paris
Erschienen in
European Journal of Orthopaedic Surgery & Traumatology / Ausgabe 4/2014
Print ISSN: 1633-8065
Elektronische ISSN: 1432-1068
DOI
https://doi.org/10.1007/s00590-013-1223-0

Weitere Artikel der Ausgabe 4/2014

European Journal of Orthopaedic Surgery & Traumatology 4/2014 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

TEP mit Roboterhilfe führt nicht zu größerer Zufriedenheit

15.05.2024 Knie-TEP Nachrichten

Der Einsatz von Operationsrobotern für den Einbau von Totalendoprothesen des Kniegelenks hat die Präzision der Eingriffe erhöht. Für die postoperative Zufriedenheit der Patienten scheint das aber unerheblich zu sein, wie eine Studie zeigt.

Lever-Sign-Test hilft beim Verdacht auf Kreuzbandriss

15.05.2024 Vordere Kreuzbandruptur Nachrichten

Mit dem Hebelzeichen-Test lässt sich offenbar recht zuverlässig feststellen, ob ein vorderes Kreuzband gerissen ist. In einer Metaanalyse war die Vorhersagekraft vor allem bei positivem Testergebnis hoch.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Aquatherapie bei Fibromyalgie wirksamer als Trockenübungen

03.05.2024 Fibromyalgiesyndrom Nachrichten

Bewegungs-, Dehnungs- und Entspannungsübungen im Wasser lindern die Beschwerden von Patientinnen mit Fibromyalgie besser als das Üben auf trockenem Land. Das geht aus einer spanisch-brasilianischen Vergleichsstudie hervor.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.